Neurovation Labs Inc.

New York, NY

UEI
XJBNST38ANE9
CAGE
7Y3R0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
330 E 38th St #20c, New York, NY 10016, USA
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Similar vendors

About the company

Neurovation Labs Inc. is a small disadvantaged, woman-owned business registered in the System for Award Management (SAM) as a corporate entity eligible to receive prime federal contract awards. According to its website, Neurovation Labs develops medical technologies focused on diagnostics and therapeutics for neurological and neuropsychiatric conditions. The company specializes in brain imaging, machine learning, and pharmaceutical development for traumatic brain injury, post-traumatic stress disorder, and other cognitive disorders.

Neurovation Labs Inc. has served as a prime contractor on several federal contracts with the Department of the Air Force Materiel Command Research Laboratory. These awards funded development of objective biomedical diagnostics for traumatic brain injury and trauma-related mental health conditions faced by military personnel. The company received a $1,249,997 firm fixed price SBIR Phase II award for this work, contributing to the Air Force's research into diagnostic tools for brain injuries. Additionally, Neurovation Labs was awarded a $749,997 Other Transaction Agreement for COVID-19 diagnostics and targeted PTSD treatments under the Defense Innovation Board Biomedical program. An earlier $49,920 SBIR Phase I award supported innovative dual-use Air Force technologies. All projects were performed in New York, NY with no subcontracting partners listed. The contract vehicles utilized include purchase orders, Other Transaction Agreements, and SBIR program funding across Phase I and Phase II stages.

Quick answers

Is Neurovation Labs Inc. registered in SAM.gov?

Yes. Neurovation Labs Inc.'s SAM.gov registration is active through June 29, 2027.

What is Neurovation Labs Inc.'s most recent federal award?

Neurovation Labs Inc.'s most recent federal contract award is Objective biomedical diagnostic for assessing traumatic brain injury (TBI) and other trauma-related mental health… (FA864922P0856), from Air Force Research Laboratory (AFMC), on June 14, 2022.

On GovTribe

See Neurovation Labs Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors